SCOPUS 정보 검색 플랫폼

Volumn 117, Issue 3, 2002, Pages 605-612

Dose escalation therapy in previously untreated patients with multiple myeloma following Z-Dex induction treatment

(8) Clark, Andrew D a Douglas, Kenneth W a Mitchell, Lyndsay D a McQuaker, I Grant a Parker, Anne N a Tansey, Patrick J b Franklin, Ian M a Cook, Gordon a,c

a UNIVERSITY OF GLASGOW (United Kingdom)

b VICTORIA INFIRMARY (United Kingdom)

c ST JAMES S UNIVERSITY HOSPITAL (United Kingdom)

Author keywords

Busulphan; Cyclophosphamide; Melphalan; Multiple myeloma; Z Dex

Indexed keywords

ACICLOVIR; BUSULFAN; CD34 ANTIGEN; CIPROFLOXACIN; CISPLATIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; FLUCONAZOLE; GAMMA INTERFERON; IDARUBICIN; MANNITOL; MELPHALAN; PENTAMIDINE; PHENYTOIN; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; AUTOGRAFT; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER SURVIVAL; CELL MOTILITY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; INFECTION PREVENTION; KIDNEY DISEASE; LIVER DISEASE; MAINTENANCE THERAPY; MALE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NAUSEA; NEUROTOXICITY; PERIPHERAL BLOOD STEM CELL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IDARUBICIN; INTERFERON ALFA-2B; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036098768 PISSN: 00071048 EISSN: None Source Type: Journal
DOI: 10.1046/j.1365-2141.2002.03519.x Document Type: Article

Times cited : (11)

References (33)

1
- 8544226948
- Comparison of peripheral blood progenitor cell mobilisation in patients with multiple myeloma: High-dose cyclophosphamide plus GM-CSF vs G-CSF alone
- (1997) Bone Marrow Transplantation , vol.20 , pp. 211-217
- Alegre, A.¹ Tomas, J.F.² Martinez-Chamorro, C.³

2
- 0028872645
- VAD chemotherapy as remission induction for multiple myeloma
- (1995) British Journal of Cancer , vol.71 , pp. 326-330
- Anderson, H.¹ Scarffe, J.H.² Ranson, M.³ Young, R.⁴ Wieringa, G.S.⁵ Morgenstern, G.R.⁶ Fitzsimmons, L.⁷ Ryder, D.⁸

3
- 0022510876
- High dose melphalan with autologous bone marrow transplantation in multiple myeloma
- (1986) Blood , vol.67 , pp. 1298-1301
- Barlogie, B.¹ Hall, R.² Zander, A.³ Dickie, K.⁴ Alexanian, R.⁵

4
- 0024325842
- Etoposide, dexamethasone, cytarabine and cisplatin in vincristine, doxorubicin and dexamethasone-refractory myeloma
- (1989) Journal of Clinical Oncology , vol.7 , pp. 1514-1517
- Barlogie, B.¹ Velasquez, W.S.² Alexanian, R.³ Cabanillas, F.⁴

5
- 34547974589
- Biology and therapy of multiple myeloma
- (1993) Seminars in Oncology , vol.20 , pp. 18-25
- Barlogie, B.¹ Jagannath, J.² Epstein, J.³ Munshi, N.⁴ Siegel, D.⁵ Desikan, K.R.⁶ Feinman, R.⁷ Hsu, P.L.⁸ Von Bremmen, K.⁹ Tricot, G.¹⁰

6
- 0031803968
- Long-term follow-up after high dose therapy for high risk multiple myeloma
- (1998) Bone Marrow Transplantation , vol.21 , pp. 1101-1107
- Barlogie, B.¹ Jagannath, S.² Naucke, S.³ Mattox, S.⁴ Barcy, D.⁵ Crowley, J.⁶ Tricot, G.⁷ Alexanian, R.⁸

7
- 9244263575
- High dose therapy followed by autologous haemopoietic stem cell infusion for patients with multiple myeloma
- (1996) Journal of Clinical Oncology , vol.14 , pp. 1447-1456
- Bensinger, W.I.¹ Rowley, S.D.² Demirer, T.³ Lilleby, K.⁴ Schiffman, K.⁵ Clift, R.A.⁶ Appelbaum, F.R.⁷ Fefer, A.⁸ Barnett, T.⁹ Storb, R.¹⁰ Chauncey, T.¹¹ Maziarz, R.T.¹² Klarnet, J.¹³ McSweeney, P.¹⁴ Holmberg, L.¹⁵ Maloney, D.G.¹⁶ Weaver, C.H.¹⁷ Buckner, C.D.¹⁸

8
- 18244428600
- Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation
- (1998) British Journal of Haematology , vol.102 , pp. 1115-1123
- Blade, J.¹ Samson, D.² Reece, D.³ Apperley, J.⁴ Bjorkstrand, B.⁵ Gahrton, G.⁶ Gertz, M.⁷ Giralt, S.⁸ Jagannath, S.⁹ Vesole, D.¹⁰

9
- 0032728628
- An analysis of which subgroups of multiple myeloma patients, divided according to beta-2 microglobulin and plasma cell labelling index, benefit from high dose versus conventional chemotherapy
- (1999) Haematologica , vol.84 , pp. 905-910
- Boccadoro, M.¹ Tarella, C.² Palumbo, A.³ Argentino, C.⁴ Triolo, S.⁵ Dominietto, A.⁶ Callea, V.⁷ Lauta, V.M.⁸ Molica, S.⁹ Musto, P.¹⁰ Marmont, F.¹¹ Gianni, A.M.¹² Pileri, A.¹³

10
- 0029942953
- A phase I/II trial of Z-Dex (idarubicin and dexamethasone), an oral equivalent of VAD, for initial response in newly diagnosed and progressive multiple myeloma
- (1996) British Journal of Haematology , vol.93 , pp. 931-934
- Cook, G.¹ Sharp, R.A.² Tansey, P.³ Franklin, I.M.⁴

11
- 0031441944
- Peripheral blood progenitor cell mobilisation in patients with multiple myeloma following oral idarubicin and dexamethasone (Z-Dex) induction therapy
- (1997) Leukaemia , vol.11 , pp. 35-40
- Cook, G.¹ Marinaki, P.² Farrell, E.³ Pearson, C.⁴ Alcorn, M.J.⁵ Sharp, R.A.⁶ Tansey, P.J.⁷ Franklin, I.M.⁸

12
- 0035103579
- The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma
- (2001) British Journal of Haematology , vol.112 , pp. 814-819
- Davies, F.E.¹ Forsyth, P.D.² Rawstron, A.C.³ Owen, R.G.⁴ Pratt, G.⁵ Evans, P.A.S.⁶ Richards, S.J.⁷ Drayson, M.⁸ Smith, G.M.⁹ Child, J.A.¹⁰ Morgan, G.J.¹¹

13
- 0027435042
- Thiotepa, busulfan and cyclophosphamide: A new preparative regime for autologous marrow or blood stem cell transplantation in high risk multiple myeloma
- (1993) Blood , vol.82 , pp. 2324-2328
- Dimopoulos, M.A.¹ Alexanian, R.² Przepiorka, D.³ Hester, J.⁴ Andersson, B.⁵ Giralt, S.⁶ Mehra, R.⁷

14
- 0032211193
- High dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: Up-front or rescue treatment? Results of a multi-centre sequential randomized clinical study
- (1998) Blood , vol.92 , pp. 3131-3136
- Fermand, J.P.¹ Ravaud, P.² Chevret, S.³ Divine, M.⁴ Leblond, V.⁵ Belanger, C.⁶ Marco, M.⁷ Pertuiset, E.⁸ Dreyfus, F.⁹ Mariette, X.¹⁰ Boccacio, C.¹¹ Brouet, J.C.¹²

15
- 0034930351
- Laboratory correlates in multiple myeloma: How useful for prognosis
- (2001) Blood Reviews , vol.15 , pp. 97-102
- Fonseca, R.¹ Conte, G.² Greipp, P.R.³

16
- 0032951029
- + sub-populations that proliferate in response to IL-6 in human myelomas
- (1999) British Journal of Haematology , vol.105 , pp. 131-140
- Fujii, R.¹ Ishikawa, H.² Mahmoud, M.S.³ Asaoku, H.⁴ Kawano, M.M.⁵

17
- 0017335337
- Cis-dichlorodiammineplatinum (II) chemotherapy in experimental murine myeloma MOPC 104E
- (1977) Cancer Research , vol.37 , pp. 771-774
- Ghanta, V.K.¹ Jones, M.T.² Woodard, D.A.³ Durant, J.R.⁴ Hiramoto, R.N.⁵

18
- 0006139949
- Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide plus GM-CSF vs G-CSF alone
- (1997) Bone Marrow Transplantation , vol.20 , pp. 211-217
- Goldschmidt, H.¹ Hegenbart, U.² Wallmeier, M.³ Hohaus, S.⁴ Haas, R.⁵

19
- 0031032214
- The role of autologous haematopoietic stem cell transplantation in multiple myeloma
- (1997) Seminars in Hematology , vol.34 , pp. 61-66
- Harousseau, J.L.¹ Attal, M.²

20
- 0027234501
- Identification of immature and mature myeloma cells in the bone marrow of human myelomas
- (1993) Blood , vol.82 , pp. 564
- Kawano, M.M.¹ Huang, N.² Harada, H.³

21
- 0034039235
- Conditioning regimens in autologous stem cell transplantation for multiple myeloma: A comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple Myeloma
- (2000) British Journal of Haematology , vol.109 , pp. 138-147
- Lahuerta, J.J.¹ Martinez-Lopez, J.² Grande, C.³ Blade, J.⁴ De la Serra, J.⁵ Allegre, A.⁶ Carcia-Larana, J.⁷ Caballero, D.⁸ Sureda, A.⁹ De la Rubia, J.¹⁰ Alvarez, A.M.¹¹ Marin, J.¹² Escudero, A.¹³ Conde, E.¹⁴ Perez-Equiza, K.¹⁵ Carcia Ruiz, J.C.¹⁶ Moraleda, J.M.¹⁷ Leon, A.¹⁸ Bargay, J.¹⁹ Cabrera, R.²⁰ more..

22
- 0035197035
- Allogeneic transplantatation for multiple myeloma: Further evidence for a GVHD-associated graft-versus-myeloma effect
- (2001) Bone Marrow Transplantation , vol.28 , pp. 841-848
- LeBlanc, R.¹ Montminy-Metivier, S.² Belanger, R.³ Busque, L.⁴ Fish, D.⁵ Roy, D.C.⁶ Kasis, J.⁷ Boileau, J.⁸ Lavallee, R.⁹ Belanger, D.¹⁰ Letendre, F.¹¹ Hebert, J.¹² Sauvageau, G.¹³ Perreault, C.¹⁴ Roy, J.¹⁵

23
- 17344363066
- Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: A monocentric study
- (1998) Leukaemia , vol.12 , pp. 1447-1456
- Marit, G.¹ Thiessard, F.² Faberes, C.³ Cony-Makhoul, P.⁴ Boiron, J.M.⁵ Bernard, P.⁶ Pigneux, A.⁷ Puntous, M.⁸ Agape, P.⁹ Vezon, G.¹⁰ Broustet, A.¹¹ Girault, D.¹² Salmi, L.R.¹³ Reiffers, J.¹⁴

24
- 0024539155
- In vitro studies of ways to overcome resistance to VAMP-HD melphalan in the treatment of multiple myeloma
- (1989) British Journal of Haematology , vol.71 , pp. 213-222
- Millar, B.C.¹ Bell, J.B.² Maitland, J.A.³ Zuiable, A.⁴ Gore, M.E.⁵ Selby, P.J.⁶ McElwain, T.J.⁷

25
- 0019365237
- Reporting results of cancer treatment
- (1981) Cancer , vol.47 , pp. 207-214
- Miller, A.B.¹ Hoogstraten, B.² Staquet, M.³ Winkler, A.⁴

26
- 0028245795
- Multiple myeloma: Expression of nucleoside transporters on malignant plasma cells and their relationship to cellular proliferation
- (1994) Leukemia and Lymphoma , vol.13 , pp. 491-499
- Petersen, A.J.¹ Brown, R.D.² Pope, B.B.³ Jamieson, G.P.⁴ Paterson, A.R.⁵ Gibson, J.⁶ Wiley, J.S.⁷ Joshua, D.E.⁸

27
- 8244254365
- A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma
- (1997) British Journal of Haematology , vol.97 , pp. 153-160
- Raje, N.¹ Powles, R.² Kulkarni, S.³ Milan, S.⁴ Middleton, G.⁵ Singhal, S.⁶ Mehta, J.⁷ Millar, B.⁸ Viner, C.⁹ Raymond, J.¹⁰ Treleaven, J.¹¹ Cunningham, D.¹² Gore, M.¹³

28
- 0034992767
- In multiple myeloma, only a single stage of neoplastic cell differentiation can be identified by VLA-5 and CD45 expression
- (2001) British Journal of Haematology , vol.113 , pp. 794-802
- Rawstron, A.C.¹ Barrans, S.L.² Blythe, D.³ English, A.⁴ Richards, S.J.⁵ Fenton, J.A.L.⁶ Davies, F.E.⁷ Child, J.A.⁸ Jack, A.S.⁹ Morgan, G.J.¹⁰

29
- 0024357763
- Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma
- (1989) Lancet , vol.2 , pp. 882-885
- Samson, D.¹ Gaminara, E.² Newland, A.³ Van de Pette, J.⁴ Kearney, J.⁵ McCarthy, D.⁶ Joyner, M.⁷ Aston, L.⁸ Mitchell, T.⁹ Hamon, M.¹⁰

30
- 0028292239
- Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma
- (1994) Bone Marrow Transplantation , vol.14 , pp. 131-136
- Schiller, G.¹ Nmer, S.² Vescio, R.³ Lee, M.⁴ Gajewski Jterrito, M.⁵ Berenson, J.⁶

31
- 0032705231
- Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed disease entity with a new staging system
- (1999) British Journal of Haematology , vol.107 , pp. 656-666
- Sirohi, B.¹ Powles, R.² Mehta, J.³ Raje, N.⁴ Kulkarni, S.⁵ Ramiah, V.⁶ Saso, R.⁷ Horton, C.⁸ Bhagwati, N.⁹ Singhal, S.¹⁰ Treleaven, J.¹¹

32
- 0035449067
- Purging of autologous peripheral blood stem cells using CD34 selection does not improve overall or progression free survival after high-dose chemotherapy for multiple myeloma: Results of a multi-centre randomized controlled trial
- (2001) Journal of Clinical Oncology , vol.19 , pp. 3771-3779
- Stewart, A.K.¹ Vescio, R.² Schiller, G.³ Ballester, O.⁴ Noga, S.⁵ Rugo, H.⁶ Freytes, C.⁷ Stadtmauer, E.⁸ Tarantalo, S.⁹ Sahebi, F.¹⁰ Stiff, P.¹¹ Meharchard, J.¹² Schloaaman, R.¹³ Brown, R.¹⁴ Tully, H.¹⁵ Benyunes, M.¹⁶ Jacobs, C.¹⁷ Berenson, R.¹⁸ White, M.¹⁹ DiPersio, J.²⁰ Anderson, K.C.²¹ Berenson, J.²² more..

33
- 0023818185
- Effective salvage therapy for lymphoma with cisplatin in combination with high dose Ara-C and dexamethasone (DHAP)
- (1988) Blood , vol.71 , pp. 117-122
- Velasquez, W.S.¹ Cabanillas, F.² Salvador, P.³ McLauhglin, P.⁴ Fredrik, M.⁵ Tucker, S.⁶ Jagannath, S.⁷ Hagemeister, F.B.⁸ Redman, J.R.⁹ Swan, F.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.